Back to search

Randomized Phase II Study of Fludarabine + Cytosine Arabinoside + Idarubicin ± All-Trans Retinoic Acid ± Granulocyte Colony-Stimulating Factor in Poor Prognosis Newly Diagnosed Acute Myeloid Leukemia and Myelodysplastic Syndrome

Data up to Jan 2025

Published1999
Citations202
References30

Total Citations Per Year

Abstract

References (30)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Robust Locally Weighted Regression and Smoothing Scatterplots

1979 • 10,049 citations

Evaluation of survival data and two new rank order statistics arising in its consideration.

1966 • 7,595 citations

Proportional hazards tests and diagnostics based on weighted residuals

1994 • 4,890 citations

Counting Processes and Survival Analysis.

1992 • 2,335 citations

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1975 • 2,224 citations

All-trans-Retinoic Acid in Acute Promyelocytic Leukemia

1997 • 1,090 citations

High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy

1993 • 738 citations

The New S Language.

1989 • 637 citations

Expression of bcl-xL can confer a multidrug resistance phenotype

1995 • 421 citations

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

1997 • 334 citations

A Controlled Study of Recombinant Human Granulocyte Colony-Stimulating Factor in Elderly Patients after Treatment for Acute Myelogenous Leukemia

1995 • 321 citations

A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031)

1998 • 310 citations

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor.

1994 • 299 citations

Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy

1997 • 238 citations

The relationship between bcl‐2 expression and response to chemotherapy in acute leukaemia

1994 • 165 citations

Measurement of Spontaneous and Therapeutic Agent-Induced Apoptosis With BCL-2 Protein Expression in Acute Myeloid Leukemia

1997 • 112 citations

034: The Conditions Under Which x2 Measures the Discrepancy Between Observation and Hypothesis.

1924 • 101 citations

The exact analysis of contingency tables in medical research

1994 • 80 citations

Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells.

1995 • 71 citations

Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute myeloblastic leukemia.

1989 • 47 citations

Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.

1996 • 36 citations

Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.

1994 • 34 citations

Treatment of Newly Diagnosed Acute Promyelocytic Leukemia (APL) by All Transretinoic Acid (ATRA) Combined with Chemotherapy: The European Experience

1995 • 32 citations

A Double-Blind Placebo-Controlled Trial of Granulocyte Colony-Stimulating Factor in Elderly Patients With Previously Untreated Acute Myeloid Leukemia: A Southwest Oncology Group Study (9031)

1998 • 21 citations

Regulation of the synthesis of bcl-2 protein by growth factors.

1996 • 18 citations

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia

1997 • 12 citations

Measurement of Spontaneous and Therapeutic Agent-Induced Apoptosis With BCL-2 Protein Expression in Acute Myeloid Leukemia

1997 • 9 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
Randomized Phase II Study of Fludarabine + Cytosine Arabinoside + Idarubicin ± All-Trans… (1999) – Blood | Metascience Observatory Explorer